Bristol-Myers Squibb Company (BMY)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $128.63B
Last updated: Nov 17, 2026 at 4:37 PM ET
Bristol-Myers Squibb Company (BMY) Stock Chart
Bristol-Myers Squibb Company (BMY) has a latest price of $62.93 on Nov 17, 2026, 7.4% below its 52-week high of $67.94. Its price rose 32.3% over the past 12 months. The month-end price rose 22.7% over the 10 years through Oct 2026, a compound annual rate of 2.1%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $80.28 in Nov 2022 and its lowest $41.09 in May 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BMY with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BMY.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 3.7%, and over 6 months it rose 12.1%. The month-end price rose 21.2% over the 3 years through Oct 2026, a compound annual rate of 6.6%.
| Period | Change |
|---|---|
| 1 month | +5.3% |
| 3 months | -3.7% |
| 6 months | +12.1% |
| 12 months | +32.3% |
| 12 months, with dividends | +37.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +21.2% | +6.6% |
| 5 years | +7.0% | +1.4% |
| 10 years | +22.7% | +2.1% |
Price by Year
Its best calendar year was 2019, when the price rose 23.5%, and its weakest was 2023, when it fell 28.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $62.48 | +15.8% |
| 2025 | $53.94 | -4.6% |
| 2024 | $56.56 | +10.2% |
| 2023 | $51.31 | -28.7% |
| 2022 | $71.95 | +15.4% |
| 2021 | $62.35 | +0.5% |
| 2020 | $62.03 | -3.4% |
| 2019 | $64.19 | +23.5% |
| 2018 | $51.98 | -15.2% |
| 2017 | $61.28 | +4.9% |
Trading Range
The price is 2.2% above its 50-day average of $61.59 and 5.5% above its 200-day average of $59.63.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $62.93 | |
| 52-week high | $67.94 | -7.4% |
| 52-week low | $43.34 | +45.2% |
| 50-day average | $61.59 | +2.2% |
| 200-day average | $59.63 | +5.5% |
Price Risk
Over 3 years, its largest fall from a peak was 30.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.23 |
| Largest fall, 1 year | -15.9% |
| Largest fall, 3 years | -30.7% |
Valuation
Bristol-Myers Squibb Company traded at 8.8x earnings at the end of 2025, against a 5-year median of 9.2x and a 10-year median of 10.2x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BMY
What is BMY's 1-year price change?
Bristol-Myers Squibb Company's price rose 32.3% over the past 12 months. With dividends included, the 12-month total return was 37.6%.
What is BMY's 5-year price change?
Bristol-Myers Squibb Company's month-end price rose 7.0% over the 5 years through Oct 2026, a compound annual rate of 1.4%. These figures leave out dividends.
What is BMY's 52-week high and low?
Bristol-Myers Squibb Company's 52-week high is $67.94 and its 52-week low is $43.34. Its latest price of $62.93 on Nov 17, 2026 is 7.4% below the high.
What is BMY's beta?
Bristol-Myers Squibb Company's 1-year beta against the S&P 500 is 0.23, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 15.9%.
Is the BMY chart free?
Yes. Advanced Charting for BMY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BMY pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts